Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cage Pharma logo — Innovative pre-clinical biopharma advancing tumor-targeting...

Cage Pharma

Innovative pre-clinical biopharma advancing tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment.

Founded 2017 0-1 employees Series Unknown Total: $967.49K Biopharma, Biotechnology +1

General Information

Company Name Cage Pharma
Founded Year 2017
Employees 0-1
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Cage Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cage Pharma

Cage Pharma is an innovative pre-clinical biopharmaceutical startup, focusing on the development of tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment. The company's encapsulated anti-cancer agent utilizes a novel formulation of 3-bromopyruvate to target cancer by attacking tumor glycolysis, a critical feature of cancer cells. This approach allows for the effective use of the anti-cancer agent while maintaining a controlled and mild toxicity profile. Founded in 2017, Cage Pharma is headquartered in Baltimore, Maryland. The company recently secured a $137.49K Venture Round investment on 31 May 2024. Cage Pharma operates in the Biopharma, Biotechnology, and Pharmaceutical industries, positioning itself at the forefront of cutting-edge cancer treatment development.

Taxonomy: pre-clinical biopharma, tumor-targeting therapy, cancer treatment, encapsulated formulations, 3-bromopyruvate, tumor metabolism, anti-cancer agent, novel formulation, controlled toxicity profile, Baltimore, Maryland, drug development, biopharmaceutical company

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 31 May 2024
Seed Round •••••• - 10 Jul 2019
Seed Round •••••• - 05 Jan 2018

Cage Pharma Alternatives & Competitors

Cage Pharma vs
Teclison
Teclison United States

Biotechnology company that specializes in the development of innovative cancer medicines

Series Unknown
9 employees
Biotechnology
Cage Pharma vs
MACROPHAGE PHARMA LIMITED
MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

Series A
Biotechnology, Pharmaceutical
Cage Pharma vs
EV Therapeutics
EV Therapeutics United States

Immunotherapy EVolved.

Unknown
2 employees
Biotechnology, Health Care

FAQ About Cage Pharma

Innovative pre-clinical biopharma advancing tumor-targeting therapies with groundbreaking encapsulated formulations for more effective cancer treatment.
Cage Pharma was founded in 2017.
Cage Pharma operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Cage Pharma has approximately 0-1 employees.
Cage Pharma has completed 3 funding rounds, raising a total of $967.49K. The latest funding stage is Series Unknown.
Top alternatives and competitors to Cage Pharma include Teclison, MACROPHAGE PHARMA LIMITED, EV Therapeutics, VerImmune, Tarveda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cage Pharma and Teclison are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cage Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy